Skip to main content
Cary Harding, MD, Medical Genetics, Portland, OR

Cary Owen Harding MD

Medical Genetics•Portland, OR

Clinical Biochemical Genetics, Clinical Genetics

Associate Professor, Molecular & Medical Genetics, Oregon Health and Science University School of Medicine

Join to view full profile

  • 707 SW Gaines StPortland, OR 97239

  • Phone+1 503-494-7859

  • Fax+1 503-494-4447

Dr. Harding is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Harding's full profileAlready have an account?

Education & Training

  • University of Wisconsin Hospitals and Clinics
    University of Wisconsin Hospitals and ClinicsResidency, Pediatrics, 1987 - 1990
  • University of Washington School of Medicine
    University of Washington School of MedicineClass of 1987

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 1999 - 2027
  • ID State Medical License
    ID State Medical License 2004 - 2024
  • WI State Medical License
    WI State Medical License 1988 - 1999
  • Clinical Biochemical Genetics
    American Board of Medical Genetics and Genomics Clinical Biochemical Genetics
  • Clinical Genetics and Genomics
    American Board of Medical Genetics and Genomics Clinical Genetics and Genomics

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • BioMarin Pharmaceutical : , Pioneer in Rare Disease Treatments for Phenylketonuria, Receives FDA Approval of Label Expansion
    BioMarin Pharmaceutical : , Pioneer in Rare Disease Treatments for Phenylketonuria, Receives FDA Approval of Label ExpansionOctober 15th, 2020
  • FDA Approves New Drug Tested at OHSU for Phenylketonuria, or PKU - Portland Business Journal
    FDA Approves New Drug Tested at OHSU for Phenylketonuria, or PKU - Portland Business JournalMay 25th, 2018
  • BioMarin Sinks Despite Meeting Primary Endpoint
    BioMarin Sinks Despite Meeting Primary EndpointMarch 21st, 2016

Grant Support

  • Hyperphenylalaninemia Disorders Consortium of the Rare Disease Clinical Research NetworkOREGON HEALTH & SCIENCE UNIVERSITY2019–2025
  • Augmented Phenylalanine Clearance By Muscles As Novel Therapy For PhenylketonuriaEunice Kennedy Shriver National Institute Of Child Health &Human Development2009–2012
  • AAV2/8 Vector-Mediated Liver Gene Therapy For Phenylketonuria (PKU)National Institute Of Diabetes And Digestive And Kidney Diseases2007–2009
  • Liver Gene Therapy For Murine Phenyketonuria (PKU)National Institute Of Diabetes And Digestive And Kidney Diseases2006
  • Intravenous Non-Viral Gene Therapy For Phenylketonuria (PKU)National Institute Of Diabetes And Digestive And Kidney Diseases2006

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Cary Harding, Dr. Cary Harding, MD, Dr. C Harding, Dr. Cary Owen Harding